Subjects to be considered in partial replicate BE study [RSABE / ABEL]

posted by Dr_Dan  – Germany, 2015-01-08 08:59 (2725 d 02:48 ago) – Posting: # 14245
Views: 27,413

Dear Detlew
I agree that the study protocol text is insufficiently verbalized. However, if a subject completes two periods, he/she can be included either in the assessment of bioequivalence (in case of one period with test and the other with reference) or in the assessment of within-subject variability of the reference product (in case both periods with reference), right?
Kind regards
Dr_Dan

Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
22,165 posts in 4,645 threads, 1,572 registered users;
online 5 (0 registered, 5 guests [including 1 identified bots]).
Forum time: Saturday 12:48 CEST (Europe/Vienna)

Absolute certainty is a privilege of uneducated minds  and fanatics.
It is, for scientific folk, an unattainable ideal.    Cassius J. Keyser

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5